Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus

This publication has 53 references indexed in Scilit:

• Disparities in Diabetes: The Nexus of Race, Poverty, and Place
  American Journal of Public Health, 2014
• Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3′ end of FBN1 gene
  European Journal of Medical Genetics, 2014
• Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
  International Journal of Endocrinology, 2014
• Severe congenital lipodystrophy and a progeroid appearance: Mutation in the penultimate exon of FBN1 causing a recognizable phenotype
  American Journal of Medical Genetics Part A, 2013
• Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3′ end of the FBN1 gene
  American Journal of Medical Genetics Part A, 2011
• Progeroid facial features and lipodystrophy associated with a novel splice site mutation in the final intron of the FBN1 gene
  American Journal of Medical Genetics Part A, 2011
• Marfan syndrome with neonatal progeroid syndrome‐like lipodystrophy associated with a novel frameshift mutation at the 3′ terminus of the FBN1‐gene
  American Journal of Medical Genetics Part A, 2010
• The metabolic syndrome
  The Lancet, 2005
• Type 2 diabetes: principles of pathogenesis and therapy
  The Lancet, 2005
• A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.
  Journal of Clinical Investigation, 1995